MoneyWorks4Me

Wockhardt gets nod to raise Rs 150 crore

22 May 2021 Evaluate

Wockhardt’s board has approved plans to raise up to Rs 150 crore by issuing securities on a private placement basis. The credit facilities committee of the board at its meeting held on May 21 has approved the raising of funds up to Rs 150 crore through issuance of rated/unrated, listed/unlisted, secured/unsecured non-convertible debentures on a private placement basis, in one or more tranches.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..